Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...

Indian doctors have introduced new guidelines to address the growing obesity crisis, categorising it into two stages and ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...

Data from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of ...

For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that from 2021 to 2023, those rates dropped from 41.9% to 40.3%.

Research reveals groundbreaking results about Mounjaro and Ozempic in weight loss treatment. Here's what you need to know ...

GLP-1 drugs have been shown to help people lose weight They also can help lower blood sugar and protect heart health The drugs work in different ways in the body to cause these effects THURSDAY ...

Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug—better known as GLP-1—for weight loss, the protocol for getting back on ...

A person with a BMI over 35 and those who would like to lose more than 20 pounds is the ideal non-diabetic candidates for GLP ...

With over $410 million in financing; to advance portfolio of next-gen oral and injectable treatments with first- or ...